Skip to main content
Top
Published in: Endocrine 1/2008

01-04-2008 | Original Paper

Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study

Authors: Cihangir Erem, Arif Hacıhasanoglu, Orhan Deger, Murat Topbaş, Ilgın Hosver, Halil Onder Ersoz, Gamze Can

Published in: Endocrine | Issue 1/2008

Login to get access

Abstract

Objective In order to estimate the prevalence of metabolic syndrome (MetS) as defined by NCEP Adult Treatment Panel III (ATP III) criteria in the Trabzon Region and its associations with demographic factors (age, sex, marital status, reproductive history in women, and level of education), socioeconomic factors (household income and occupation), family history of selected medical conditions (diabetes, hypertension, and obesity), lifestyle factors (smoking habits, physical activity, and alcohol consumption) in the adult population. Research Methods and Procedures In this cross-sectional survey, a sample of households was systematically selected from the central province of Trabzon and its nine towns. A total of 4,809 adult subjects ≥20 years (2,601 women and 2,208 men) were included in the study. Blood pressure levels were measured for all subjects. The persons included in the questionnaire were invited to the local medical centers for blood examination between 08:00 and 10:00 following 12 h of fasting. Fasting serum glucose (FBG) levels and lipid profile were measured with autoanalyzer. MetS was defined according to guidelines from the NCEP ATP III diagnostic criteria. Results The prevalence of MetS was 26.9%: 31.3 in women and 21.7% in men. The prevalence increased with age, being highest in the 60–69-year-old age group (53.4%) but lower again in the ≥70 age group. MetS was associated positively with marital status, parity, cessation of cigarette smoking, and negatively with the level of education, alcohol consumption, current cigarette use, household income, and physical activity. Hypertension was found as the most common MetS component in our study (57.4%). Others in decreasing order were abdominal obesity (40.9%), low high-density lipoprotein-C (HDL-C) (31.8%), hypertriglyceridemia (30.7%), and high FBG levels (9.2%). Similarly, in the subjects diagnosed with MetS, HT had the highest prevalence (91.9%). This was followed by abdominal obesity (82.3%), hypertriglyceridemia (74%), low HDL-C (68.6%), and high fasting blood glucose levels (28.6%). Discussion MetS is moderately common and an important health problem in the adult population of Trabzon. In order to control MetS and its components, effective public health education and taking urgent steps are needed. These steps include serious education, providing a well-balanced diet and increasing physical activity.
Literature
1.
go back to reference P.J. Miranda, R.A. DeFronzo, R.M. Califf, J.R. Guyton, Metabolic syndrome: definition, pathophysiology, and mechanisms. Am. Heart J. 149, 33–45 (2005)CrossRefPubMed P.J. Miranda, R.A. DeFronzo, R.M. Califf, J.R. Guyton, Metabolic syndrome: definition, pathophysiology, and mechanisms. Am. Heart J. 149, 33–45 (2005)CrossRefPubMed
2.
go back to reference E. Ferrannini, S.M. Haffner, B.D. Mitchell, M.P. Stern, Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34, 416–422 (1991)CrossRefPubMed E. Ferrannini, S.M. Haffner, B.D. Mitchell, M.P. Stern, Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34, 416–422 (1991)CrossRefPubMed
3.
go back to reference A. Fontbonne, Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia 37, 953–955 (1994)CrossRefPubMed A. Fontbonne, Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia 37, 953–955 (1994)CrossRefPubMed
4.
go back to reference R.L. Hanson, G. Imperatore, P.H. Bennett, W.C. Knowler, Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes 51, 3120–3127 (2002)CrossRefPubMed R.L. Hanson, G. Imperatore, P.H. Bennett, W.C. Knowler, Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes 51, 3120–3127 (2002)CrossRefPubMed
5.
go back to reference B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, M.R. Taskinen, L. Groop, Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683–689 (2001)CrossRefPubMed B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, M.R. Taskinen, L. Groop, Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683–689 (2001)CrossRefPubMed
6.
go back to reference Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III). JAMA. 285, 2486–2497 (2001) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III). JAMA. 285, 2486–2497 (2001)
7.
go back to reference S.W. Oh, Y.S. Yoon, E.S. Lee, W.K. Kim, Association between cigarette smoking and metabolic syndrome. Diabetes Care 28, 2064–2066 (2005)CrossRefPubMed S.W. Oh, Y.S. Yoon, E.S. Lee, W.K. Kim, Association between cigarette smoking and metabolic syndrome. Diabetes Care 28, 2064–2066 (2005)CrossRefPubMed
8.
go back to reference Y.S. Yoon, S.W. Oh, H.W. Baik, H.S. Park, W.Y. Kim, Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 80, 217–224 (2004)PubMed Y.S. Yoon, S.W. Oh, H.W. Baik, H.S. Park, W.Y. Kim, Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 80, 217–224 (2004)PubMed
9.
go back to reference S. Yoo, T. Nicklas, T. Baranowski, I.F. Zakeri, S.J. Yang, S.R. Srinivasan, G.S. Berenson, Comparison of dietary intakes associated with metabolic syndrome risk factors in young adults: Bogalusa Heart Study. Am. J. Clin. Nutr. 80, 841–848 (2004)PubMed S. Yoo, T. Nicklas, T. Baranowski, I.F. Zakeri, S.J. Yang, S.R. Srinivasan, G.S. Berenson, Comparison of dietary intakes associated with metabolic syndrome risk factors in young adults: Bogalusa Heart Study. Am. J. Clin. Nutr. 80, 841–848 (2004)PubMed
10.
go back to reference C.L. Scott, Diagnosis, prevention and intervention for the metabolic syndrome. Am. J. Cardiol. 92(Suppl), 35i–42i (2003) C.L. Scott, Diagnosis, prevention and intervention for the metabolic syndrome. Am. J. Cardiol. 92(Suppl), 35i–42i (2003)
11.
go back to reference A.O. Rantala, H. Kauma, M. Lilja, M.J. Savolainen, A. Reunanen, Y.A. Kesaniemi, Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J. Intern. Med. 245, 163–174 (1999)CrossRefPubMed A.O. Rantala, H. Kauma, M. Lilja, M.J. Savolainen, A. Reunanen, Y.A. Kesaniemi, Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J. Intern. Med. 245, 163–174 (1999)CrossRefPubMed
12.
go back to reference A.J. Cameron, J.E. Shaw, P.Z. Zimmet, The metabolic syndrome: prevalence in worldwide populations. Endocrinol. Metab. Clin. N. Am. 33, 351–375 (2004)CrossRef A.J. Cameron, J.E. Shaw, P.Z. Zimmet, The metabolic syndrome: prevalence in worldwide populations. Endocrinol. Metab. Clin. N. Am. 33, 351–375 (2004)CrossRef
13.
go back to reference A. Gupta, R. Gupta, M. Sarna, S. Rastogi, V.P. Grupta, K. Kothari, Prevalence of diabetes, impaired fasting glucose and insulin resistence syndrome in an urban Indian population. Diabetes Res. Clin. Pract. 61, 69–76 (2003)CrossRefPubMed A. Gupta, R. Gupta, M. Sarna, S. Rastogi, V.P. Grupta, K. Kothari, Prevalence of diabetes, impaired fasting glucose and insulin resistence syndrome in an urban Indian population. Diabetes Res. Clin. Pract. 61, 69–76 (2003)CrossRefPubMed
14.
go back to reference E.S. Ford, W.H. Giles, W.H. Dietz, Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287, 356–359 (2002)CrossRefPubMed E.S. Ford, W.H. Giles, W.H. Dietz, Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287, 356–359 (2002)CrossRefPubMed
15.
go back to reference B. Balkau, M. Vernay, L. Mhamdi, M. Novak, D. Arondel, S. Vol, J. Ticket, E. Eschwege, The D.E.S.I.R study group, The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab. 29, 526–532 (2003)CrossRefPubMed B. Balkau, M. Vernay, L. Mhamdi, M. Novak, D. Arondel, S. Vol, J. Ticket, E. Eschwege, The D.E.S.I.R study group, The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab. 29, 526–532 (2003)CrossRefPubMed
16.
go back to reference A. Ramachandran, C. Snehalatha, K. Satyavani, S. Sivasankari, V. Vijay, Metabolic syndrome in urban Asian Indian Adults—a population study using modified ATP III criteria. Diabetes Res. Clin. Pract. 60, 199–204 (2003)CrossRefPubMed A. Ramachandran, C. Snehalatha, K. Satyavani, S. Sivasankari, V. Vijay, Metabolic syndrome in urban Asian Indian Adults—a population study using modified ATP III criteria. Diabetes Res. Clin. Pract. 60, 199–204 (2003)CrossRefPubMed
17.
go back to reference C. Erem, C. Arslan, A. Hacihasanoglu, O. Deger, M. Topbaş, K. Ukinc, H.Ö. Ersöz , M. Telatar, Prevalence of obesity and associated risk factors in a Turkish population (Trabzon City, Turkey). Obes. Res. 12, 1117–1127 (2004)CrossRefPubMed C. Erem, C. Arslan, A. Hacihasanoglu, O. Deger, M. Topbaş, K. Ukinc, H.Ö. Ersöz , M. Telatar, Prevalence of obesity and associated risk factors in a Turkish population (Trabzon City, Turkey). Obes. Res. 12, 1117–1127 (2004)CrossRefPubMed
18.
go back to reference C. Erem, R. Yıldız, H. Kavgacı, C. Karahan, O. Değer, G. Çan, M. Telatar, Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon City). Diabetes Res. Clin. Pract. 54, 203–208 (2001)CrossRefPubMed C. Erem, R. Yıldız, H. Kavgacı, C. Karahan, O. Değer, G. Çan, M. Telatar, Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon City). Diabetes Res. Clin. Pract. 54, 203–208 (2001)CrossRefPubMed
19.
go back to reference I. Satman, T. Yilmaz, A. Sengul, S. Salman, F. Salman, S. Uygur, I. Bastar, Y. Tutuncu, M. Sargin, N. Dinccag, K. Karsidag, S. Kalaca, C. Ozcan, H. King, The TURDEP Group, Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care 25, 1551–1556 (2002)CrossRefPubMed I. Satman, T. Yilmaz, A. Sengul, S. Salman, F. Salman, S. Uygur, I. Bastar, Y. Tutuncu, M. Sargin, N. Dinccag, K. Karsidag, S. Kalaca, C. Ozcan, H. King, The TURDEP Group, Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care 25, 1551–1556 (2002)CrossRefPubMed
20.
go back to reference A. Onat, K. Ceyhan, O. Basar, S. Toprak, V. Sansoy, Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation. Atherosclerosis 165, 285–292 (2002)CrossRefPubMed A. Onat, K. Ceyhan, O. Basar, S. Toprak, V. Sansoy, Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation. Atherosclerosis 165, 285–292 (2002)CrossRefPubMed
21.
go back to reference A.K. Ozsahin, A. Gökcel, N. Sezgin, M. Akbaba, N. Güvener, I. Ozisik, B.M. Karademir, Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr. Metab. 17, 230–234 (2004)PubMed A.K. Ozsahin, A. Gökcel, N. Sezgin, M. Akbaba, N. Güvener, I. Ozisik, B.M. Karademir, Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr. Metab. 17, 230–234 (2004)PubMed
22.
go back to reference M.I. Schmidt, B.B. Duncan, R.L. Watson, A.R. Sharrett, F.L. Brancati, G. Heiss, A metabolic syndrome in whites and African-Americans: the atherosclerosis risk in communities baseline study. Diabetes Care 19, 414–418 (1996)CrossRefPubMed M.I. Schmidt, B.B. Duncan, R.L. Watson, A.R. Sharrett, F.L. Brancati, G. Heiss, A metabolic syndrome in whites and African-Americans: the atherosclerosis risk in communities baseline study. Diabetes Care 19, 414–418 (1996)CrossRefPubMed
23.
go back to reference K. Gu Dongfeng Reynolds, X. Wu, J. Chen, X. Duan, R.F. Reynolds, P.K. Whelton, J. He, The interASIA Collaborative Group, Prevalence of the metabolic syndrome and overweight among adults in Chine. Lancet 365, 1398–1405 (2005)CrossRef K. Gu Dongfeng Reynolds, X. Wu, J. Chen, X. Duan, R.F. Reynolds, P.K. Whelton, J. He, The interASIA Collaborative Group, Prevalence of the metabolic syndrome and overweight among adults in Chine. Lancet 365, 1398–1405 (2005)CrossRef
24.
go back to reference L.N.T.D. Son, D. Kunii, N.T.K. Hung, T. Sakai, S. Yamamoto, The metabolic syndrome: prevalence and risk factors in the urban population of Ho Chi Minh City. Diabetes Res. Clin. Pract. 67, 243–250 (2005)CrossRef L.N.T.D. Son, D. Kunii, N.T.K. Hung, T. Sakai, S. Yamamoto, The metabolic syndrome: prevalence and risk factors in the urban population of Ho Chi Minh City. Diabetes Res. Clin. Pract. 67, 243–250 (2005)CrossRef
25.
go back to reference F. Azizi, P. Salehi, A. Etemadi, S. Zahedi-Asl, Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res. Clin. Pract. 61, 29–37 (2003)CrossRefPubMed F. Azizi, P. Salehi, A. Etemadi, S. Zahedi-Asl, Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res. Clin. Pract. 61, 29–37 (2003)CrossRefPubMed
26.
go back to reference V.G. Athyros, V.I. Bouloukos, A.N. Pehlivanidis, A.A. Papageorgiou, S.G. Dionysopoulou, A.N. Symeonidis, D.I. Petridis, M.I. Kapousouzi, E.A. Satsoglou, Mikhailidis DP, The MetS-Greece Collabotarive Group, The prevalence of the metabolic syndrome in Greece: The MetS-Greece Multicentre Study. Diabetes Obes. Metab. 7, 397–405 (2005) V.G. Athyros, V.I. Bouloukos, A.N. Pehlivanidis, A.A. Papageorgiou, S.G. Dionysopoulou, A.N. Symeonidis, D.I. Petridis, M.I. Kapousouzi, E.A. Satsoglou, Mikhailidis DP, The MetS-Greece Collabotarive Group, The prevalence of the metabolic syndrome in Greece: The MetS-Greece Multicentre Study. Diabetes Obes. Metab. 7, 397–405 (2005)
27.
go back to reference F.E.R. Punzalan, R.G. Sy, T. Ty-Willing, Prevalence of metabolic syndrome among adult Filipinos. Int. Congr. Ser. 1262, 442–445 (2004)CrossRef F.E.R. Punzalan, R.G. Sy, T. Ty-Willing, Prevalence of metabolic syndrome among adult Filipinos. Int. Congr. Ser. 1262, 442–445 (2004)CrossRef
28.
go back to reference R. Gupta, P.C. Deedwania, A. Gupta, S. Rastogi, R.B. Panwar, K. Kothari, Prevalence of metabolic syndrome in an Indian urban population. Int. J. Cardiol. 97, 257–261 (2004)CrossRefPubMed R. Gupta, P.C. Deedwania, A. Gupta, S. Rastogi, R.B. Panwar, K. Kothari, Prevalence of metabolic syndrome in an Indian urban population. Int. J. Cardiol. 97, 257–261 (2004)CrossRefPubMed
29.
go back to reference W.-Y. Lee, J.-S. Park, S.-Y. Noh, E.-J. Rhee, S.-W. Kim, P.Z. Zimmet, Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res. Clin. Pract. 65, 143–149 (2004)CrossRefPubMed W.-Y. Lee, J.-S. Park, S.-Y. Noh, E.-J. Rhee, S.-W. Kim, P.Z. Zimmet, Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res. Clin. Pract. 65, 143–149 (2004)CrossRefPubMed
30.
go back to reference R. Miccoli, C. Bianchi, L. Odoguardi, G. Penno, F. Caricato, M.G. Giovannitti, L. Pucci, S. Del Prato, Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr. Metab. Cardiovasc. Dis. 15, 250–254 (2005)CrossRefPubMed R. Miccoli, C. Bianchi, L. Odoguardi, G. Penno, F. Caricato, M.G. Giovannitti, L. Pucci, S. Del Prato, Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr. Metab. Cardiovasc. Dis. 15, 250–254 (2005)CrossRefPubMed
31.
go back to reference H.S. Park, S.W. Oh, S.-I. Cho, W.H. Choi, Y.S. Kim, The metabolic syndrome and associated lifestyle factors among South Korean adults. Int. J. Epidemiol. 33, 328–336 (2004)CrossRefPubMed H.S. Park, S.W. Oh, S.-I. Cho, W.H. Choi, Y.S. Kim, The metabolic syndrome and associated lifestyle factors among South Korean adults. Int. J. Epidemiol. 33, 328–336 (2004)CrossRefPubMed
32.
go back to reference C.A. Aguilar-Salinas, R. Rojas, F.J. Gomez-Perez, V. Valles, J.M. Rios-Torres, A. Franco, G. Olaiz, J.A. Rull, J. Sepulveda, High prevalence of metabolic syndrome in Mexico. Arch. Med. Res. 35, 76–81 (2004)CrossRefPubMed C.A. Aguilar-Salinas, R. Rojas, F.J. Gomez-Perez, V. Valles, J.M. Rios-Torres, A. Franco, G. Olaiz, J.A. Rull, J. Sepulveda, High prevalence of metabolic syndrome in Mexico. Arch. Med. Res. 35, 76–81 (2004)CrossRefPubMed
33.
go back to reference J.-Y. Oh, Y.S. Hong, Y.-A. Sung, E. Barrett-Connor, Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Dibetes Care 27, 2027–2032 (2004)CrossRef J.-Y. Oh, Y.S. Hong, Y.-A. Sung, E. Barrett-Connor, Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Dibetes Care 27, 2027–2032 (2004)CrossRef
34.
go back to reference WHO, Obesity: preventing and managing the global epidemic (WHO, Geneva, 1998) WHO, Obesity: preventing and managing the global epidemic (WHO, Geneva, 1998)
35.
go back to reference J. Lidfeldt, P. Nyberg, C. Nerbrand, G. Samsione, B. Schersten, C.D. Agardh, Socio-demogaphic and psychosocial factors are associated with features of the metabolic syndrome. The Women’s Health in the Lund Area (WHILA) study. Diabetes Obes. Metab. 5, 106–112 (2003)CrossRefPubMed J. Lidfeldt, P. Nyberg, C. Nerbrand, G. Samsione, B. Schersten, C.D. Agardh, Socio-demogaphic and psychosocial factors are associated with features of the metabolic syndrome. The Women’s Health in the Lund Area (WHILA) study. Diabetes Obes. Metab. 5, 106–112 (2003)CrossRefPubMed
36.
go back to reference S.P. Wamala, J. Lynch, M. Horsten, M.A. Mittleman, K. Schenck-Gustafsson, K. Orth-Gomer, Education and the metabolic syndrome in women. Diabetes Care 22, 1999–2003 (1999)CrossRefPubMed S.P. Wamala, J. Lynch, M. Horsten, M.A. Mittleman, K. Schenck-Gustafsson, K. Orth-Gomer, Education and the metabolic syndrome in women. Diabetes Care 22, 1999–2003 (1999)CrossRefPubMed
37.
go back to reference R. Choiniere, P. Lafontaine, A.C. Edwards, Distribution of cardiovascular disease risk factors by socioeconomic status among Canadian adults. Can. Med. Assoc. J. 162, S13–S24 (2000) R. Choiniere, P. Lafontaine, A.C. Edwards, Distribution of cardiovascular disease risk factors by socioeconomic status among Canadian adults. Can. Med. Assoc. J. 162, S13–S24 (2000)
38.
go back to reference A.M. Rissanen, M. Heliovaara, P. Knekt, A. Reunanen, A. Aromaa, Determinants of weight gain and overweight in adult Finns. Eur. J. Clin. Nutr. 45, 419–430 (1991)PubMed A.M. Rissanen, M. Heliovaara, P. Knekt, A. Reunanen, A. Aromaa, Determinants of weight gain and overweight in adult Finns. Eur. J. Clin. Nutr. 45, 419–430 (1991)PubMed
39.
go back to reference Y.W. Park, S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethon, S.B. Heymsfield, The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch. Intern. Med. 163, 427–436 (2003)CrossRefPubMed Y.W. Park, S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethon, S.B. Heymsfield, The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch. Intern. Med. 163, 427–436 (2003)CrossRefPubMed
40.
go back to reference T.M. Tahtinen, M.J. Vanhala, J.A. Oikarinen, S.M. Keinanen-Kiukaanniemi, Effect of smoking on the prevalence of insulin resistance-associated cardiovascular risk factors among Finnish men in military service. J. Cardiovasc. Risk. 5, 319–323 (1998)CrossRefPubMed T.M. Tahtinen, M.J. Vanhala, J.A. Oikarinen, S.M. Keinanen-Kiukaanniemi, Effect of smoking on the prevalence of insulin resistance-associated cardiovascular risk factors among Finnish men in military service. J. Cardiovasc. Risk. 5, 319–323 (1998)CrossRefPubMed
41.
go back to reference S. Attvall, J. Fowelin, I. Lager, H. Von Schenck, U. Smith, Smoking induces insulin resistance-a potential link with the insulin resistance syndrome. J. Intern. Med. 233, 327–332 (1993)CrossRefPubMed S. Attvall, J. Fowelin, I. Lager, H. Von Schenck, U. Smith, Smoking induces insulin resistance-a potential link with the insulin resistance syndrome. J. Intern. Med. 233, 327–332 (1993)CrossRefPubMed
42.
go back to reference F.S. Facchini, C.B. Hollenbeck, J. Jeppesen, Y.D. Chen, G.M. Reaven, Insulin resistance and cigarette smoking. Lancet 339, 1128–1130 (1992)CrossRefPubMed F.S. Facchini, C.B. Hollenbeck, J. Jeppesen, Y.D. Chen, G.M. Reaven, Insulin resistance and cigarette smoking. Lancet 339, 1128–1130 (1992)CrossRefPubMed
43.
go back to reference C. Kong, L. Nimmo, T. Elatrozy, V. Anyaoku, C. Hughes, S. Robinson, W. Richmond, R.S. Elkeles, Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis 156, 373–378 (2002)CrossRef C. Kong, L. Nimmo, T. Elatrozy, V. Anyaoku, C. Hughes, S. Robinson, W. Richmond, R.S. Elkeles, Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis 156, 373–378 (2002)CrossRef
44.
go back to reference A.S. Leon, J. Connett, D.R. Jacobs Jr., R. Rauramaa, Leisure-time physical activity levels and risk of coronary heart disease and death: the Multiple Risk Factor Intervention Trial. JAMA 258, 2388–2395 (1987)CrossRefPubMed A.S. Leon, J. Connett, D.R. Jacobs Jr., R. Rauramaa, Leisure-time physical activity levels and risk of coronary heart disease and death: the Multiple Risk Factor Intervention Trial. JAMA 258, 2388–2395 (1987)CrossRefPubMed
45.
go back to reference J. Pekkanen, B. Marti, A. Nissinen, J. Tuomilehto, S. Punsar, M.J. Karvonen, Reduction of premature mortality by high physical activity: a 20-year follow-up of middle-aged Finnish men. Lancet 255, 1473–1477 (1987)CrossRef J. Pekkanen, B. Marti, A. Nissinen, J. Tuomilehto, S. Punsar, M.J. Karvonen, Reduction of premature mortality by high physical activity: a 20-year follow-up of middle-aged Finnish men. Lancet 255, 1473–1477 (1987)CrossRef
46.
go back to reference P.S. Denker, V.E. Pollock, Fasting serum insulin levels in essential hypertension. A meta-analysis. Arch. Intern. Med. 152, 1649–1651 (1992)CrossRefPubMed P.S. Denker, V.E. Pollock, Fasting serum insulin levels in essential hypertension. A meta-analysis. Arch. Intern. Med. 152, 1649–1651 (1992)CrossRefPubMed
47.
go back to reference World Health Organization, The World Health Report 2000: Health System Efficiency (WHO, Geneva, 2000) World Health Organization, The World Health Report 2000: Health System Efficiency (WHO, Geneva, 2000)
48.
go back to reference R. Ross, D. Dagnone, P.J. Jones, H. Smith, A. Paddags, R. Hudson, I. Janssen, Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men: a randomized, cotrolled trial. Ann. Intern. Med. 133, 92–103 (2000)PubMed R. Ross, D. Dagnone, P.J. Jones, H. Smith, A. Paddags, R. Hudson, I. Janssen, Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men: a randomized, cotrolled trial. Ann. Intern. Med. 133, 92–103 (2000)PubMed
Metadata
Title
Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study
Authors
Cihangir Erem
Arif Hacıhasanoglu
Orhan Deger
Murat Topbaş
Ilgın Hosver
Halil Onder Ersoz
Gamze Can
Publication date
01-04-2008
Publisher
Springer US
Published in
Endocrine / Issue 1/2008
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-008-9044-3

Other articles of this Issue 1/2008

Endocrine 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.